Alfred Health’s highly successful PrEPX study for those at risk for HIV infection will be expanded into Tasmania thanks to funding from the Tasmanian Government.
PrEPX closed enrolments on March 31.
PrEP became available on PBS on April 1 and is now accessible through your regular GP or sexual health doctor. For people accessing PrEPX post April 1, you can see your GP to get a normal script, as the study will have completed.
There will be a difference in the cost of PrEP as you will need to pay a co-payment for each script.
If you have any questions about finding a GP to access PrEP please contact us on (03) 9076 2940.
The PrEPX Study is also being conducted in Victoria and South Australia:
What is PrEPX-Tasmania?
PrEPX in Tasmania will monitor how providing large-scale access to Pre-Exposure Prophylaxis (PrEP) medication impacts the rate of new infections across the state. There will be 100 places available in the study.
This study is funded by the Tasmanian Government and is planned to open in September 2017.
Where will PrEPX be available?
Three clinics will offer enrolments for PrEPX. Please contact these clinics to register for participation in PrEPX-Tasmania.
- Clinic 60, 60 Collins Street, Hobart 7000. Phone: (03) 6166 0990
- Clinic 34, 34 Howick Street, Launceston 7250. Phone: (03) 6777 1371
- SHS, 23 Steele Street, Devonport 7310. Phone via Launceston: (03) 6777 1371
Before you attend your clinic appointment please watch the PrEPX video which will explain a lot about PrEP. Also read the consent form as you will need to sign a copy at your clinic appointment.
What costs are involved?
A PBS co-payment for the study medication will be in place for PrEPX study participants.
We plan that the medication will be able to be collected from pharmacies near each clinic.
- Concession: $6:40
- Non-concession: $39.50
In the study this co-payment cost will cover three months’ supply.
Criteria for the study
All people, regardless of sexual orientation or gender are eligible for the study. PrEPX will enroll people whose sexual or injecting drug use activities means there is a high risk of acquiring HIV infection. This level of risk is defined through discussions with doctors, nurses or peer workers.
To be eligible for the study you will need to:
- have a medicare card
- be over 18 years of age
- have no confounding health issues for the study
More detailed criteria is available on the consent form attached below.
Information about PrEP
HIV Pre-Exposure Prophylaxis (PrEP) is a once-a-day medication for HIV negative people, to reduce their risk of acquiring HIV. It is recommended that PrEP is taken every day to effectively reduce the risk.